CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
radiotherapyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00001189
NCT00001189Phase 2Completed
CompareCT.gov

The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors

National Cancer Institute (NCI)·interventional·Posted Dec 10, 2002·Updated Mar 4, 2008

In Brief

A Phase 2 clinical trial evaluating radiotherapy for Sarcoma and Neoplasms. Completed, across 1 site.

Detailed Summary

Patients with Grade I soft tissue sarcomas or benign, non-metastasizing invasive soft tissue tumors will receive wide local excision and be prospectively randomized as to either receive or not receive radiation therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSarcoma, Neoplasms
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 10, 2002
Enrollment StartDec 1, 1983
Study CompletionApr 1, 2001
TodayJul 2, 2026
Posted 23.6 years ago

Interventions

radiotherapyprocedure